Amerisourcebergen (ABC) Részvény Árfolyam
Amerisourcebergen Árfolyam
Az elmúlt 19 évben a(z) Amerisourcebergen árbevétele évi 9,0%-kal nőtt, és elérte a 337,40 Md USD-t. Az egy részvényre jutó eredmény évi 15,1%-kal nőtt az elmúlt 19 évben. A(z) Amerisourcebergen esetében a 1,0%-os nettó árrés nagyrészt stabil a néhány évvel ezelőtti 0,7%-hoz képest. A mai áron az osztalékhozam nagyjából 0,42%. A kifizetési ráta a nyereség körülbelül 17%-a. Az osztalék évi 17,3%-kal nőtt az elmúlt 16 évben. A(z) Amerisourcebergen 12 hónapos konszenzusos célára 213,18 USD, körülbelül alatt az árfolyamot 38,9%-kal. 21 elemzőből 14 vételt javasol — az összesített konszenzus Vétel.
Amerisourcebergen részvényár
Ezeket az adatokat az Eulerpool API-n keresztül
100 000 kérés/hó ingyen · nincs bankkártya
Amerisourcebergen üzleti modell és részvényelemzés
Gyakran feltett kérdések a Amerisourcebergen részvényről
AmerisourceBergen Corp is a leading global pharmaceutical sourcing and distribution company. Its business model primarily focuses on providing pharmaceutical products and services to various healthcare providers, including hospitals, pharmacies, and physicians. As a key player in the healthcare supply chain, AmerisourceBergen operates through three main segments: Pharmaceutical Distribution Services, Global Commercialization Services, and Animal Health. Through these segments, the company offers a comprehensive range of services, including sourcing, packaging, logistics, and technology solutions. AmerisourceBergen Corp collaborates with pharmaceutical manufacturers to ensure the efficient delivery of vital medications and healthcare products to patients worldwide.
AmerisourceBergen Corp primarily operates in the pharmaceutical distribution industry.
The main competitors of AmerisourceBergen Corp in the market include McKesson Corporation and Cardinal Health Inc. These companies are key players in the pharmaceutical distribution industry, providing similar services and products. AmerisourceBergen Corp competes with these rivals in terms of market share, customer relationships, and supply chain management. These competitors also operate on a global scale, catering to the needs of healthcare providers and pharmaceutical manufacturers. Overall, AmerisourceBergen faces strong competition from McKesson Corporation and Cardinal Health Inc in its efforts to maintain its position as a leading player in the pharmaceutical distribution market.
AmerisourceBergen Corp, founded in 2001, is a global healthcare solutions company based in the United States. It specializes in pharmaceutical sourcing and distribution services, serving both pharmaceutical manufacturers and healthcare providers. With its extensive network of distribution centers, AmerisourceBergen offers a wide range of products and services to support patient care and deliver vital medications. The company has a rich history of growth and innovation, expanding its operations globally and establishing itself as a leader in the healthcare industry. AmerisourceBergen continues to evolve and adapt to the changing needs of the healthcare landscape, striving to improve patient outcomes and advance the delivery of healthcare services.
AmerisourceBergen Corp, a leading global healthcare solutions company, has achieved several significant milestones. The company has consistently expanded its market reach through strategic acquisitions and partnerships, solidifying its position as a major player in the pharmaceutical distribution industry. AmerisourceBergen Corp has also demonstrated its commitment to innovation by adopting advanced technologies and enhancing its digital capabilities. Furthermore, the company's strong financial performance, consistent revenue growth, and successful execution of its business strategies have contributed to its continuous success and recognition as a Fortune 11 company. AmerisourceBergen Corp's dedication to serving the healthcare needs of patients and providing exceptional value to its customers have allowed it to become a trusted partner in the industry.
AmerisourceBergen Corp is primarily present in the United States, one of the largest pharmaceutical markets globally. With headquarters in Pennsylvania, the company operates in various regions across the US, including key cities like California, New York, Texas, and Florida. AmerisourceBergen provides pharmaceutical distribution and related services to a wide range of healthcare providers, including hospitals, pharmacies, and physician practices. With a strong presence across the American healthcare landscape, AmerisourceBergen Corp plays a vital role in ensuring the efficient and reliable distribution of pharmaceutical products throughout the United States.
AmerisourceBergen Corp represents a strong commitment to integrity, innovation, and collaboration. The company values client relationships and aims to provide superior service by fulfilling the healthcare needs of their customers. With a mission to improve patient access to pharmaceuticals and medical products, AmerisourceBergen Corp operates under the corporate philosophy that emphasizes reliable distribution networks, cutting-edge technology solutions, and industry expertise. By leveraging their extensive network, they work towards delivering exceptional value to healthcare providers and pharmaceutical manufacturers. AmerisourceBergen Corp strives to foster a culture of trust, integrity, and transparency, ensuring sustainable growth and success in the healthcare industry.
Az elemzők jelenleg 213,76 USD átlagos célárat adnak a Amerisourcebergen részvényre (medián: 213,18 USD), ami -35,9 % a legutóbbi árhoz képest. A konszenzus 21 elemzői minősítésen alapul.
20 elemző értékeli jelenleg a Amerisourcebergen részvényt: 13 vételt, 7 tartást és 0 eladást javasol.
Az aktuális árfolyamon a Amerisourcebergen részvény 311,72 EUR (348,71 USD).
A Amerisourcebergen részvény (ABC) 8 tőzsdén jegyzett, többek között: NYSE (ABC), London (0HF3.L), SIX (Zürich) (ABGCHF.SW), XETRA (ABG.DE), Frankfurt (ABG.F), München (ABG.MU), Düsseldorf (ABG.DU).
AmerisourceBergen Corp is an international company based in the USA that specializes in providing innovative solutions in the healthcare industry. The company offers a wide range of products and services that enable healthcare facilities to operate more efficiently and improve patient care. The business model of AmerisourceBergen Corp is based on three main business areas: 1. Pharmaceutical Distribution: The company is one of the largest pharmaceutical distributors in North America and offers a wide range of products and services to meet the demand for pharmaceuticals and medications. This includes specialty pharmaceuticals, biosimilars, and generics. 2. Outsourcing Services: AmerisourceBergen offers a variety of outsourcing services, including medication manufacturing, supply chain support, and consultation and training for healthcare professionals. 3. Value Assessment: Lastly, AmerisourceBergen provides value assessment services that enable customers to better understand and communicate the impact and benefits of their products. Together, these three business areas form the foundation of AmerisourceBergen's business model and enable the company to offer a variety of products and services to improve the quality of patient care and efficiency in the healthcare industry. One example of the products offered by AmerisourceBergen is oncology therapies. The company is a major provider of cancer medications in North America. It also works closely with insurance companies and other partners to ensure that cancer patients have access to necessary treatments and services. This product is an example of how AmerisourceBergen combines its core business areas to meet the demand for innovative solutions in healthcare. SEO-optimized terms found in this text include "pharmaceutical distributors," "outsourcing services," "value assessment services," and "oncology therapies." These terms are used to clarify the topic of the text and increase traffic to the AmerisourceBergen website by being found by search engines. By using such key terms, the text also strengthens the online visibility of AmerisourceBergen and contributes to improving the company's online marketing strategy.
A bevétele Amerisourcebergen 337,40 Md USD. Ez az érték az aktuális pénzügyi adatokon alapul, és a vállalat üzleti teljesítményét tükrözi.
A nyeresége Amerisourcebergen 3,48 Md USD. A nettó nyereség a vállalat nyereségességét tükrözi az összes költség levonása után.
A Amerisourcebergen ár/nyereség mutatója (P/E) jelenleg 19,43. A P/E mutató az aktuális részvényárat az egy részvényre jutó nyereséggel hasonlítja össze, és segít a befektetőknek a Amerisourcebergen részvény értékelésének megértésében.
A Amerisourcebergen ár/értékesítés mutatója (P/S) jelenleg 0,20. A P/S mutató a piaci kapitalizációt az éves bevételhez hasonlítja, és a Amerisourcebergen részvény értékelési mérőszámaként szolgál.
Az Eulerpool minőségi pontszáma a Amerisourcebergen számára 8/10.
A Amerisourcebergen ISIN-je US03073E1055. Az ISIN (International Securities Identification Number) a nemzetközi securities azonosító.
A Amerisourcebergen WKN-je 766149. A WKN (Wertpapierkennnummer) egy hatjegyű német értékpapír-azonosító szám.
A Amerisourcebergen ticker-e ABC. A ticker szimbólum a Amerisourcebergen részvény tőzsdei kereskedésénél használatos.
Amerisourcebergen részvény
Amerisourcebergen Peer Group
Amerisourcebergen Tőzsdei rövidítés
Amerisourcebergen FIGI
A Amerisourcebergen összes alapfundamentuma és mélyreható elemzése
A Amerisourcebergen részvény Eulerpool-elemzése olyan fontos pénzügyi mutatókat tartalmaz, mint a bevétel, nyereség, P/E arány, P/S arány, EBIT, valamint információk az osztalékról. Vizsgáljuk a részvények, piaci kapitalizáció, adósság, saját tőke és kötelezettségek vonatkozásait is Amerisourcebergen. Ha részletesebb információt keres ezekről a témákról, részletes elemzéseket kínálunk az aloldalainkon.